Regulatory T cells promote cancer immune-escape through integrin αvβ8-mediated TGF-β activation
Year: 2021
Type: article
Abstract: Presence of TGFβ in the tumor microenvironment is one of the most relevant cancer immune-escape mechanisms. TGFβ is secreted in an inactive form, and its activation within the tumor may depend on different cell types and mechanisms than its production. Here we show in mouse melanoma and breast cancer models that regulatory T (Treg) cells expressing the β8 chain of αvβ8 integrin (Itgβ8) are the main cell type in the tumors that activates TGFβ, produced by the cancer cells and stored in the tumor micro-environment. Itgβ8 ablation in Treg cells impairs TGFβ signalling in intra-tumoral T lymphocytes but not in the tumor draining lymph nodes. Successively, the effector function of tumor infiltrating CD8 + T lymphocytes strengthens, leading to efficient control of tumor growth. In cancer patients, anti-Itgβ8 antibody treatment elicits similar improved cytotoxic T cell activation. Thus, this study reveals that Treg cells work in concert with cancer cells to produce bioactive-TGFβ and to create an immunosuppressive micro-environment.
Source: Nature Communications
Institutions: Lyon 1 Université, Centre National de la Recherche Scientifique, Inserm, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Centre International de Recherche en Infectiologie, Hospices Civils de Lyon, Hôpital Lyon Sud, University of California, San Francisco, Manchester Academic Health Science Centre, Wellcome Centre for Cell-Matrix Research, University of Manchester
Language: English
Topic: TGF-β signaling in diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,885
Funders: Deutsches Krebsforschungszentrum, European Commission, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Fondation ARC pour la Recherche sur le Cancer, Ligue Contre le Cancer, Institut National Du Cancer, Direction Générale de l’offre de Soins, LabEx DEvweCAN, Medical Research Council, HORIZON EUROPE Marie Sklodowska-Curie Actions
Awards: alpha-v-beta-8 integrin expression regulation and its role in immune homeostasis in the gut, G2332505756, G269758517, G3148510052, A novel pathway in the control of memory T cell function during immune responses to viral re-infection., G6986775308, G7376787254, G774514602, Development Cancer and Targeted Therapies, G8364260751, Regulation of alpha-v-beta-8 integrin expression and its role in intestinal immune homeostasis, LYriCAN : Manipulating cell plasticity for innovative cancer treatment
OpenAlex ID: W3208753274
